Characterization and Pathogenicity of Two Novel PRRSVs Recombined by NADC30-like and NADC34-like Strains in China

Viruses. 2022 Sep 30;14(10):2174. doi: 10.3390/v14102174.

Abstract

Porcine reproductive and respiratory syndrome viruses (PRRSVs) pose a serious threat to the swine industry in China, which has caused great difficulties for porcine reproductive and respiratory syndrome (PRRS) immune prevention and control, due to its easily mutable and recombinant nature. In this study, two novel PRRSV strains, which were named GD-H1 and GD-F1, were isolated and fully sequenced from pig farms in Guangdong province, China. The phylogenetic analysis and recombination analysis revealed that the GD-H1 and GD-F1 were generated by the recombination of NADC30-like and NADC34-like strains which were different from the previously prevalent strain. Further pathogenic studies on piglets and sows found that the recombinant strains could cause piglets high fever, loss of appetite and lung lesions, but no piglets died. However, the recombinant strains could cause acute death and abortion in pregnant sow infection models together with average survival rates of 62.5% and 37.5% abortion rates, respectively. These findings indicated that the recombinant strains were extremely pathogenic to sows. Therefore, we report two clinical novel recombinant strains of PRRSV that are different from the traditional epidemic strains in China, which may provide early warning and support for PRRS immune prevention and control.

Keywords: PRRSV; pathogenicity; phylogenetic analyses; recombination analyses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • China / epidemiology
  • Genetic Variation
  • Genome, Viral
  • Phylogeny
  • Porcine Reproductive and Respiratory Syndrome* / prevention & control
  • Porcine respiratory and reproductive syndrome virus* / genetics
  • Swine
  • Virulence

Grants and funding

This work was supported by the Guangdong basic and applied basic research fund: [GrantNumber 2019B1515210030].